Opportunity

Simpler Grants.gov #PAR-27-029

NIH Cooperative Agreement for National Swine Resource and Research Center Support

Buyer

National Institutes of Health

Posted

May 06, 2026

Respond By

January 25, 2027

Identifier

PAR-27-029

NAICS

541715

This opportunity from the National Institutes of Health (NIH) seeks a cooperative agreement to support the National Swine Resource and Research Center (NSRRC): - Government Buyer: - National Institutes of Health (NIH), Office of Research Infrastructure Programs (ORIP) - No specific OEMs or commercial vendors are named, as this is a research infrastructure grant - Requested Services: - Creation, breeding, cryopreservation, and distribution of genetically modified swine models for biomedical research - Genotyping and phenotyping services for swine models - Infectious disease monitoring of swine colonies - Distribution of research protocols and training on care and use of swine models - Development of alternative or complementary methodologies to in vivo models - Notable Requirements: - Must provide consistent, high-quality, specific pathogen-free swine models - Serve as a centralized national resource for the biomedical research community - Lead in developing and sharing best practices and protocols - No specific products, part numbers, or quantities are requested; the focus is on comprehensive services and infrastructure support for the NSRRC

Description

This Notice of Funding Opportunity (NOFO) seeks applications to provide continuing support for a National Swine Resource and Research Center (NSRRC). The NSRRC will serve as a centralized national resource for creating, breeding, cryopreserving, and distributing genetically modified models to support biomedical research. It aims to reduce variability and improve reproducibility by providing consistent, high-quality, specific pathogen-free models. The center also offers genotyping, phenotyping, infectious disease monitoring, protocol distribution, and training related to the care and use of these models. Additionally, it leads the development of alternative or complementary approaches alongside in vivo models.

View original listing